We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

143 hedge funds and large institutions have $927M invested in Sage Therapeutics in 2016 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 72 increasing their positions, 27 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 27

71% more call options, than puts

Call options by funds: $3.63M | Put options by funds: $2.12M

67% more funds holding in top 10

Funds holding in top 10: 6 → 10 (+4)

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

4% more funds holding

Funds holding: 137 → 143 (+6)

32% less capital invested

Capital invested by funds: $1.37B → $927M (-$440M)

Holders
143
Holders Change
+6
Holders Change %
+4.38%
% of All Funds
3.81%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.27%
New
29
Increased
72
Reduced
27
Closed
21
Calls
$3.63M
Puts
$2.12M
Net Calls
+$1.51M
Net Calls Change
+$3.24M

Top Buyers

1
O
OppenheimerFunds
New York
+$26.4M
2
CAM
Cormorant Asset Management
Massachusetts
+$22.2M
3
DM
Deerfield Management
New York
+$18.1M
4
VAM
Visium Asset Management
New York
+$17.1M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$16.5M

Top Sellers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$19.8M
2
HCMT
Highland Capital Management (Texas)
Texas
-$8.92M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$7.7M
4
OAM
Oxford Asset Management
United Kingdom
-$6.75M
5
GGHC
Gilder Gagnon Howe & Co
New York
-$5.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
51
Guggenheim Capital
Illinois
$2.21M -$4.65K -132 -0.2%
CS
52
Candriam SCA
Luxembourg
$2.2M -$253K -7,200 -9%
SIM
53
Spark Investment Management
New York
$2.1M +$2.31M +65,500 New
BIM
54
BlackRock Investment Management
Delaware
$1.98M +$286K +8,128 +15%
Jacobs Levy Equity Management
55
Jacobs Levy Equity Management
New Jersey
$1.95M +$2.14M +60,720 New
Bank of America
56
Bank of America
North Carolina
$1.94M -$82.1K -2,331 -4%
Marshall Wace
57
Marshall Wace
United Kingdom
$1.9M +$956K +27,148 +85%
HTC
58
Hershey Trust Company
Pennsylvania
$1.89M – – –
NIP
59
Nicholas Investment Partners
California
$1.88M -$113K -3,209 -5%
Lazard Asset Management
60
Lazard Asset Management
New York
$1.84M – – –
Charles Schwab
61
Charles Schwab
California
$1.74M +$509K +14,449 +36%
TCIM
62
TIAA CREF Investment Management
New York
$1.74M +$114K +3,227 +6%
DCM
63
Driehaus Capital Management
Illinois
$1.71M +$978K +27,796 +109%
PMAM
64
Picton Mahoney Asset Management
Ontario, Canada
$1.71M -$134K -3,800 -7%
Invesco
65
Invesco
Georgia
$1.27M +$1.4M +39,687 New
TAM
66
Tocqueville Asset Management
New York
$1.27M +$22.9K +650 +2%
PAMU
67
Pictet Asset Management (UK)
United Kingdom
$1.21M +$1.45M +41,300 New
CS
68
Credit Suisse
Switzerland
$1.17M +$1.05M +29,736 +446%
AA
69
ALPS Advisors
Colorado
$1.15M -$70.9K -2,013 -5%
USAA
70
United Services Automobile Association
Texas
$1.15M +$144K +4,100 +13%
Bessemer Group
71
Bessemer Group
New Jersey
$1.08M +$35.9K +1,019 +3%
California State Teachers Retirement System (CalSTRS)
72
California State Teachers Retirement System (CalSTRS)
California
$1.06M +$262K +7,433 +29%
Swiss National Bank
73
Swiss National Bank
Switzerland
$1.02M +$549K +15,600 +89%
WC
74
Wexford Capital
Florida
$974K +$1.07M +30,396 New
ProShare Advisors
75
ProShare Advisors
Maryland
$821K +$13.8K +391 +2%
1 2
3
4 5

SAGE Hedge Fund Activity: Q1 2016 in Review

143 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q1 2016, worth a combined $927M — down 32% from $1.37B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SAGE positions and 21 closed out — a net gain of 8 holders — while 72 added to existing stakes and 27 trimmed.

The largest buyer was OppenheimerFunds, opening a new position worth an estimated $26.4M. The largest seller was Lord, Abbett & Co, cutting an estimated $19.8M.

  • 143 institutional investors held Sage Therapeutics (SAGE) as of Q1 2016, up from 137 in Q4 2015.
  • Funds reported $927M of Sage Therapeutics stock for Q1 2016, down 32% quarter-over-quarter.
  • 29 funds opened new Sage Therapeutics positions in Q1 2016 and 21 closed out, a net change of +8 holders.
  • The largest Sage Therapeutics buyer in Q1 2016 was OppenheimerFunds, an estimated $26.4M added.
  • The largest Sage Therapeutics seller in Q1 2016 was Lord, Abbett & Co, an estimated $19.8M sold.

Based on aggregated 13F filings for Q1 2016.